Format

Send to

Choose Destination
Clin Transl Oncol. 2015 May;17(5):365-70. doi: 10.1007/s12094-014-1240-4. Epub 2014 Nov 6.

Interleukin-8 promotes human ovarian cancer cell migration by epithelial-mesenchymal transition induction in vitro.

Author information

1
Department of Gynecology, The Ninth People's Hospital of Chongqing, 69 JiaLing Road, Chongqing, 400700, People's Republic of China.

Abstract

PURPOSE:

It has been well established that high serum levels of interleukin-8 (IL-8) in ovarian cancer result in a poor clinical outcome. Thus, the aim of this study was investigating the role of IL-8 in ovarian cancer development.

METHODS:

Two human ovarian cancer cell lines (SKOV3 and OVCAR3) were cocultured with IL-8 (100 ng/L) for 24 h, then cell migration was determined by transwell assay. Epithelial-mesenchymal transition (EMT)-associated proteins including E-cadherin and β-catenin, and phosphorylation status of β-catenin were investigated by Western blot analysis.

RESULTS:

After treatment with IL-8 (100 ng/L) for 24 h, transwell assay result showed that the number of migrated ovarian cells increased significantly. Western blot analysis revealed that protein levels of E-cadherin were decreased, while that of β-catenin were elevated both in IL-8 pretreated SKOV3 and OVCAR3 cells. We further found that phosphorylation status of β-catenin were elevated either in cytoplasm or in nucleus of these two ovarian cancer cell lines after treatment with IL-8 for 24 h.

CONCLUSIONS:

Our data suggest that IL-8 induces EMT in ovarian cancer cells and implicates its potential role in enhancing ovarian cancer cell metastasis.

PMID:
25373532
DOI:
10.1007/s12094-014-1240-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center